Monoclonal gammopathy

ValidICD-10-CM diagnosis code.

Valid for claims with a date of service in the current code year.

Valid FY2016 onwards.

What has happened to this code

Every change the publisher made, from 2007 to now. Entries marked draft are from the pre-implementation releases: ICD-10 took effect on 1 October 2015, so nothing before FY2016 was ever valid on a claim.

FY2007 Added to the draft code set draft Monoclonal gammopathy

Official coding rules

Published by CDC for FY2027. A rule attached to a category binds every code beneath it, so the rules inherited from this code's ancestors are shown with the code they come from.

Inherited from the D37-D48 section Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48)

Excludes1 - never coded here

neoplasms of unspecified behavior (D49.-)

Note

Categories D37-D44, and D48 classify by site neoplasms of uncertain behavior, i.e., histologic confirmation whether the neoplasm is malignant or benign cannot be made.

How CDC's index refers to this code

Wording from the official alphabetic index. Much of it appears nowhere in the code description, which is why a search for the everyday phrase so often finds nothing.

Gammopathy
Myeloma > smoldering
Syndrome > Schnitzler
Gammopathy > monoclonal
Paraproteinemia > monoclonal
Macroglobulinemia > monoclonal
Paraproteinemia > secondary to malignant disease
Gammopathy > associated with lymphoplasmacytic dyscrasia

Codes in the same group

Code	Description	Status
D47.0	Mast cell neoplasms of uncertain behavior	Not billable
D47.1	Chronic myeloproliferative disease	Valid
D47.3	Essential (hemorrhagic) thrombocythemia	Valid
D47.4	Osteomyelofibrosis	Valid
D47.9	Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified	Valid
D47.Z	Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue	Not billable